Evan de Joya (@edejoya) profile picture

Evan de Joya

@edejoya

Resident Physician | PGY3 in Otolaryngology - Head & Neck Surgery @UTHealthHouston | ‘23 MD/MS in Genomic Medicine @umiamimedicine

 Houston, TX
scholar.google.com/citations?user=r4PYzAEAAAAJ&hl=en
Joined April 2012
  • Tweets130
  • Following1.4K
  • Followers436
9Media
Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)Photo by Evan de Joya (@edejoya)
I’m going to be an otolaryngologist! Grateful for all those that have brought me here!👂 👃 👅
Image from Evan de Joya (@edejoya)
16
1
420
11,772
First day of intern year with an awesome team! 🙌 – at Houston, TX
Natalie Drucker (@NatalieADrucker) profile pictureNatalie Drucker@NatalieADrucker1 Jul 2023
Replying to @NatalieADrucker
Happy July 1! Hug an intern today from @UTH_Pedisurg
Image from Natalie Drucker (@NatalieADrucker)
1
13
1,507
Goodbye lunch with my professor, @ImeldaMoise! We met in 2015 when I was taking her class on immigrant and refugee health @univmiami. She introduced me to research and has been my mentor for the past 8 years. It is tough to say bye but I have been so fortunate to learn from her! – at Coral Gables, FL
Image from Evan de Joya (@edejoya)
Image from Evan de Joya (@edejoya)
13
811
Evan de Joya retweeted
ACMG (@TheACMG) profile picture
ACMG
@TheACMG18 Mar 2023
Congratulations, @Steven_Lang97 - welcome to the wonderful, supportive family of medical geneticists! And your #Match2023 triumph came on the last day of #MedicalGeneticsAwareness Week! Good luck @BaylorGenetics residency.
Steven Lang, M.D. (@Steven_Lang97) profile pictureSteven Lang, M.D.@Steven_Lang9717 Mar 2023
I am thrilled to share that I have matched into the pediatrics-medical genetics residency program at Baylor College of Medicine. So grateful for the support of my wonderful friends, family, and mentors along this incredible journey! @bcmgenetics @BCM_Pediatrics #Match2023
Image from Steven Lang, M.D. (@Steven_Lang97)
1
2
20
3,459
Hot of the press!! Subbiah @VivekSubbiah and I share our view. Universal germline and tumor genomic testing needed to win the war against cancer: Genomics IS the diagnosis. JCO 2023
Vivek Subbiah, MD (@VivekSubbiah) profile pictureVivek Subbiah, MD
@VivekSubbiah18 Mar 2023
🚨HOT off the press @ASCO @JCO_ASCO 👉 Delighted to share our Opinion in COMMENTS & CONTROVERSIES section ✅Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: "Genomics Is the Diagnosis" 🎯🧬 @Dr_R_Kurzrock @oncoalert ascopubs.org/doi/abs/10.1200…
Image from Vivek Subbiah, MD (@VivekSubbiah)
11
48
7,466
After an incredible 8 years @univmiami I’m thrilled to be headed to Houston for this next chapter! #match2023 #otomatch
Image from Evan de Joya (@edejoya)
6
3
162
5,187
Thank you @FeliciaKnaul for this important work and advocacy!
Felicia Knaul (@FeliciaKnaul) profile pictureFelicia Knaul
@FeliciaKnaul17 Mar 2023
Do you have cancer family history? Proposed Medicare bill seeks to expand genetic testing - thank you @DWStweets news.yahoo.com/cancer-family…
576
So inspired by our @TheLancet Commission #Cancer & #Health Systems 2-day meeting hosted by @TecdeMonterrey @GTorreAmione New tools r being created to raise the bar and close cancer divides. – at Álvaro Obregón, Distrito Federal
Image from Felicia Knaul (@FeliciaKnaul)
17
8
84
22,952
“It seemed absolutely crazy. The idea that an Iowa housewife, equipped with the cutting-edge medical tool known as Google Images, would make a medical discovery about a pro athlete who sees doctors and athletic trainers as part of her job?” propublica.org/article/muscu…
Image from Omar Wasow | @owasow@bsky.social (@owasow)
169
1,485
660
8,284
2,830,373
.@emilylmullin continues a superb effort reporting on genome editing. This excellent read showcases clinical progress of a @davidrliu @NicoleGaudelli @KomorLab invention, #CRISPR-driven base editing. @VerveTx + @BeamTx are expanding its clinical use. wired.com/story/a-more-elega…
A More Elegant Form of Gene Editing Progresses to Human Testing

A More Elegant Form of Gene Editing Progresses to Human Testing

Instead of cutting out chunks of the genome to disable malfunctioning genes, base editing makes a smaller, more precise swap.

wired.com
1
9
1
37
6,366
Hoy celebramos la 4ta sesión de la Comisión @TheLancet sobre #Cáncer y Sistemas de #Salud para evaluar el progreso hacia la Cobertura Universal en #Salud y armar nuestra agenda de trabajo para la próxima reunión presencial en #México 🇲🇽 Gracias a tod@s por sus valiosos aportes!
Image from Felicia Knaul (@FeliciaKnaul)
1
8
33
Evan de Joya retweeted
Barbara Marte (@BarbMarte) profile picture
Barbara Marte@BarbMarte9 Nov 2022
new out in Nature: nature.com/articles/s41586-0…
Spatial genomics maps the structure, nature and evolution of cancer clones

Spatial genomics maps the structure, nature and evolution of cancer clones

Nature - A workflow centred around base-specific in situ sequencing generates detailed maps of, and can phenotypically characterize, the unique set of subclones of cancers.

nature.com
81
1
286
Interesting article and thread
Jason Sheltzer (@JSheltzer) profile pictureJason Sheltzer@JSheltzer17 Oct 2022
New from my lab: we show that a clinical-stage oncology drug from Eli Lilly is mischaracterized, and its true anti-cancer target is EGFR. We also show how in vitro drug assays can be misleading - cellular+genetic methods are needed to determine drug MOAs. biorxiv.org/content/10.1101/…
A drug’s most potent target is not necessarily the source of its anti-cancer activity

A drug’s most potent target is not necessarily the source of its anti-cancer activity

The small-molecule drug ralimetinib was developed as an inhibitor of the kinase p38α, and it has advanced to phase 2 clinical trials in oncology. Here, we apply a multi-modal approach to demonstrate...

biorxiv.org
1
Yikes vice.com/en/article/pkgma8/p…
Police Are Using DNA to Generate 3D Images of Suspects They've Never Seen

Police Are Using DNA to Generate 3D Images of Suspects They've Never Seen

“Releasing one of these Parabon images to the public like the Edmonton Police did recently, is dangerous and irresponsible, especially when that image implicates a Black person and an immigrant.”

vice.com
BREAKING NEWS: The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”
Image from The Nobel Prize (@NobelPrize)
463
12,671
2,696
36,779
25M Americans live outside cancer centers’ catchment areas, @AACI_Cancer-@KimmelCancerCtr study finds cancerletter.com/conversatio…

25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds - The Cancer...

Up to 15% of U.S. counties—home to about 25 million Americans—fall outside the reach of the catchment area of this country’s cancer centers. To access this subscriber-only content please log in or...

cancerletter.com
2
3
Genomics company Illumina just unveiled its fastest, most cost-efficient DNA sequencer yet. The machine will deliver a $200 human genome and will be able to generate 20,000 of them a year. wired.com/story/the-era-of-f…
The Era of Fast, Cheap Genome Sequencing Is Here

The Era of Fast, Cheap Genome Sequencing Is Here

Illumina just announced a machine that can crack genomes twice as fast as its current version—and drive the cost down to $200 a pop.

wired.com
19
299
58
1,166
Five years ago @MikeGrunwald wrote about Cape Coral, FL, and how a major storm could drown it. Hurricane Ian is making landfall right there, right now. politico.com/magazine/story/…
The Boomtown That Shouldn’t Exist

The Boomtown That Shouldn’t Exist

Cape Coral, Florida, was built on total lies. One big storm could wipe it off the map. Oh, and it’s also the fastest-growing city in the United States.

politico.com
10
117
21
271
Another day at #ESMO22 another win for neoadjuvant immunotherapy. this time with stage II-IV cutaneous SCC. neoadjuvant cemiplimab induces 50.6% pathCR, 63.3% combined path response. Co-published @NEJM congrats @DrNeilGross @MDAndersonNews
Image from Hussein Tawbi, MD, PhD (@HTawbi_MDPhD)
1
23
3
83
#ESMO2022 Can’t wait to share the results of our confirmatory, multicenter trial of neoadjuvant immunotherapy in resectable #CSCC @myESMO @MDAndersonNews #oncsurgery #EndCancer
5
15
2
84
Load more